One of the common illness found among women is migraine headaches. But because of the several health risks, these headaches can be difficult to treat amongst the elderly women. While the hormone therapy has been effective in treating many symptoms of menopause, safety of its use in women to treat migraine was unconfirmed. A new research based on the information from Women’s Health Initiative (WHI) showed the safe use of hormone therapy to treat migraine among women. The results of this study will be presented at The North American Menopause Society (NAMS) Annual Meeting in Philadelphia, from October 11 to 14.
There have been few research activities showing the effect of the hormone therapy on migraine and consequent cardiovascular disorders. Hormones have not been prescribed often for treating migraine sufferers due to the relation between use of exogenous estrogen and an additional risk of stroke among women who are suffering from migraine. This resulted to the recommendation that birth control pills should be use with caution or entirely avoided in women suffering from migraines.
During this new research, data on 67,903 participants were examined and analyzed to find out any relationship between cardiovascular disorders and migraines and the interaction with use of hormone therapy. It was seen that the women with migraine opted to exercise and drink less than those without suffering from migraines. These women had higher intake of calcium and vitamin D. They were also more vulnerable to have hot flashes and sweat nights. The overall result of the study was positive in terms of safety of use, as there was no effect of hormone therapy on the relationship between cardiovascular disorders and migraine.